{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:46:46Z","timestamp":1784216806826,"version":"3.55.0"},"reference-count":29,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Celgene, a Bristol Myers Squibb Company."}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Hematology"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Patients with lower-risk myelodysplastic syndromes (MDS) may experience anemia and a high transfusion burden, alongside a risk of progression to acute myeloid leukemia. Luspatercept, a recombinant fusion protein that acts as an erythroid maturation agent, was FDA\/EMA-approved in 2020 based on the phase III MEDALIST trial. There remains an unmet need for anemia treatment in Asian patients for whom red blood cell (RBC) transfusion is a standard of care, and in whom rates\/severity of anemia and serum erythropoietin levels are often higher versus Western patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The objective of this study was to assess the efficacy, safety, and tolerability of luspatercept in Asian patients with anemia due to transfusion-dependent lower-risk MDS with ring sideroblasts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>This was a phase II, single-arm, interventional bridging study (NCT04477850).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients from China and Japan with very low-, low-, or intermediate-risk MDS with ring sideroblasts who were RBC transfusion-dependent received subcutaneous luspatercept starting at 1.0 mg\/kg every 3 weeks. The primary endpoint was RBC transfusion independence (TI) \u2a7e8 weeks (weeks 1\u201324).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>There was a statistically significant, clinically meaningful improvement of anemia in Asian patients; 60% ( n = 18, p &lt; 0.0001) achieved RBC-TI for \u2a7e8 weeks and 43% ( n = 13) for \u2a7e12 weeks (weeks 1\u201324). Safety was consistent with the known profile of luspatercept in MDS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These results support luspatercept as a well-tolerated, efficacious alternative to transfusions for Asian patients with lower-risk MDS, who tend to have more severe anemia. Trial registration: clinicaltrials.gov, NCT04477850.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20406207251321715","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:09:15Z","timestamp":1740103755000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Safety and efficacy of luspatercept in treating anemia associated with myelodysplastic syndrome with ring sideroblasts in Asian patients who require red blood cell transfusions: a phase II bridging study"],"prefix":"10.1177","volume":"16","author":[{"given":"Chunkang","family":"Chang","sequence":"first","affiliation":[{"name":"Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Kitasato University Hospital, Sagamihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Tong","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Usuki","sequence":"additional","affiliation":[{"name":"NTT Medical Center Tokyo, Shinagawa City, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4015-3952","authenticated-orcid":false,"given":"Qifa","family":"Liu","sequence":"additional","affiliation":[{"name":"Nanfang Hospital of Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Fujisaki","sequence":"additional","affiliation":[{"name":"Matsuyama Red Cross Hospital, Matsuyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[{"name":"Peking Union Medical College Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibin","family":"Huang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Nanchang University, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Morita","sequence":"additional","affiliation":[{"name":"Kindai University Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Miao","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Osaka Metropolitan University Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu (Olivia)","family":"Tian","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Pu","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimple","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Pozharskaya","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Shi","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8008-7385","authenticated-orcid":false,"given":"Zhijian","family":"Xiao","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, No. 288, Nanjing Road, Heping District, Tianjin, 300020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinuko","family":"Mitani","sequence":"additional","affiliation":[{"name":"Dokkyo Medical University, 880 Kitakobayashi, Mibu, Shimotsuga, Tochigi 321-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"bibr1-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61901-7"},{"key":"bibr2-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2005.01.004"},{"key":"bibr3-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1"},{"key":"bibr4-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-011-1389-7"},{"key":"bibr5-20406207251321715","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20140042"},{"key":"bibr6-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-420489"},{"key":"bibr7-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1016\/1040-8428(92)90054-T"},{"key":"bibr8-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2013.07.003"},{"key":"bibr9-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2013.09.007"},{"key":"bibr10-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04272.x"},{"key":"bibr11-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(11)70100-X"},{"key":"bibr12-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.03.004"},{"key":"bibr13-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2006.06.004"},{"key":"bibr14-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.7038"},{"key":"bibr15-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-02838-5"},{"key":"bibr16-20406207251321715","first-page":"89","volume":"40","author":"Chinese Society of Hematology and Chinese Medical Association","year":"2019","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"bibr17-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3468"},{"key":"bibr18-20406207251321715","unstructured":"REBLOZYL\n                      \u00ae\n                      (luspatercept-aamt) (package insert). Princeton, NJ: Bristol Myers Squibb Company, 2023."},{"key":"bibr19-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178674"},{"key":"bibr20-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-123064"},{"key":"bibr21-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908892"},{"key":"bibr22-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178546"},{"key":"bibr23-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00874-7"},{"key":"bibr24-20406207251321715","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-024-02510-6"},{"key":"bibr25-20406207251321715","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030481"},{"key":"bibr26-20406207251321715","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2021.22.12.4037"},{"key":"bibr27-20406207251321715","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow SH","year":"2017","edition":"4"},{"key":"bibr28-20406207251321715","unstructured":"National Health Commission of the People\u2019s Republic of China. Statistical bulletin of China's health development 2021, http:\/\/www.nhc.gov.cn\/guihuaxxs\/s3586s\/202207\/51b55216c2154332a660157abf28b09d.shtml (2022, accessed 19 June 2024)."},{"key":"bibr29-20406207251321715","unstructured":"World Health Organization. Global status report on blood safety and availability 2021, https:\/\/www.who.int\/publications\/i\/item\/9789240051683 (2022, accessed 19 June 2024)."}],"container-title":["Therapeutic Advances in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406207251321715","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20406207251321715","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406207251321715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:17:41Z","timestamp":1777591061000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20406207251321715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":29,"alternative-id":["10.1177\/20406207251321715"],"URL":"https:\/\/doi.org\/10.1177\/20406207251321715","relation":{},"ISSN":["2040-6207","2040-6215"],"issn-type":[{"value":"2040-6207","type":"print"},{"value":"2040-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"article-number":"20406207251321715"}}